The impact of polytrauma on sRAGE levels: evidence and statistical analysis of temporal variations

Abstract Background According to recently published findings, levels of the soluble receptor of advanced glycation end products (sRAGE) and its clearance from the blood may reflect the evolution of lung damage during hospitalization. Thus, the objective of this study was to reveal the course of sRAG...

Full description

Bibliographic Details
Published in:	World Journal of Emergency Surgery
Main Authors:	Lukas L. Negrin, Robin Ristl, Gabriel Halat, Thomas Heinz, Stefan Hajdu
Format:	Article
Language:	English
Published:	BMC 2019-03-01
Subjects:	Polytrauma Thoracic trauma Soluble receptor of advanced glycation end products sRAGE Biomarker
Online Access:	http://link.springer.com/article/10.1186/s13017-019-0233-6

Similar Items

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2021-07-01)

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
by: Paolo Molinari, et al.
Published: (2021-12-01)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
by: Lara Caldiroli, et al.
Published: (2022-06-01)

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
by: Agnieszka Nowak, et al.
Published: (2021-12-01)

sRAGE levels are decreased in plasma and sputum of COPD secondary to biomass-burning smoke and tobacco smoking: Differences according to the rs3134940 AGER variant
by: Ingrid Fricke-Galindo, et al.
Published: (2024-04-01)

Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases
by: Hidenori Koyama, et al.
Published: (2007-01-01)

Oleic Acid Status Positively Correlates with the Soluble Receptor for Advanced Glycation End-Products (sRAGE) in Healthy Adults Who Are Homozygous for G Allele of RAGE G82S Polymorphism
by: Permal Deo, et al.
Published: (2023-06-01)

sRAGE as a Prognostic Biomarker in ARDS: Insights from a Clinical Cohort Study
by: Ana Andrijevic, et al.
Published: (2025-01-01)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Level and Its Prognostic Significance in Children with Acute Lymphoblastic Leukemia
by: Busra Ozkan, et al.
Published: (2024-01-01)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
by: Diana Elizabeth González-Guerrero, et al.
Published: (2023-04-01)

Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Pediatric Asthma: A Prospective Study in 68 Children Aged 7 Years
by: Julie Magnier, et al.
Published: (2022-06-01)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2019-03-01)

Association between the soluble receptor for advanced glycation end products and diabetes mellitus: systematic review and meta-analysis
by: Qimou Chen, et al.
Published: (2024-10-01)

Concentrations of N<sup>6</sup>-Carboxymethyllysine (CML), N<sup>6</sup>-Carboxyethyllysine (CEL), and Soluble Receptor for Advanced Glycation End-Products (sRAGE) Are Increased in Psoriatic Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2022-12-01)

High glucose reduces Nrf2-dependent cRAGE release and enhances inflammasome-dependent IL-1β production in monocytes: the modulatory effects of EGCG
by: Chi-Hao Wu, et al.
Published: (2024-05-01)

Effects of acute aerobic exercise on circulating sTLR and sRAGE profiles in normal‐ and abnormal‐glucose‐tolerant individuals
by: Ryan K. Perkins, et al.
Published: (2023-11-01)

Soluble receptor for advanced glycation end products (sRAGE) is associated with obesity rates: a systematic review and meta-analysis of cross-sectional study
by: Nahla A Tayyib, et al.
Published: (2023-12-01)

Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study
by: Jacopo Sabbatinelli, et al.
Published: (2022-06-01)

Effects of Probucol on plasma amyloid-β transport in patients with hyperlipidemia: a 12-week randomized, double-blind, placebo-controlled trial
by: Liangjun Dang, et al.
Published: (2024-12-01)

Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD
by: Elena Dozio, et al.
Published: (2020-12-01)

Involvement of RAGE and Oxidative Stress in Inflammatory and Infectious Skin Diseases
by: Fabrizio Guarneri, et al.
Published: (2021-01-01)

Soluble receptor for advanced glycation end product (sRAGE) levels in adolescents with obesity, insulin resistance and metabolic syndrome: A case-control study and the review of the literature
by: Pembe Soylu Ustkoyuncu, et al.
Published: (2025-09-01)

Significant Interrelations among Serum Annexin A1, Soluble Receptor for Advanced Glycation End Products (sRAGE) and rs2070600 in Chronic Obstructive Pulmonary Disease
by: Amira A. Kamel, et al.
Published: (2022-11-01)

Serum sRAGE, sRANKL and osteoprotegerin in subgroups of rheumatoid arthritis patients: biomarkers associated with iron and disease status
by: Ginka Delcheva, et al.
Published: (2023-03-01)

Assessing Pulmonary Epithelial Damage in Hantavirus Cardiopulmonary Syndrome: Challenging the Predominant Role of Vascular Endothelium through sRAGE as a Potential Biomarker
by: Gabriela Meza-Fuentes, et al.
Published: (2023-09-01)

Association between Advanced Glycation End-Products and Sarcopenia in Patients with Chronic Kidney Disease
by: Paolo Molinari, et al.
Published: (2022-06-01)

Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study
by: Paolo Molinari, et al.
Published: (2023-01-01)

Evaluation of circulating sRAGE in osteoporosis according to BMI, adipokines and fracture risk: a pilot observational study
by: Emanuela Galliera, et al.
Published: (2017-06-01)

RAGE in Neutrophils: A Sensor for Pathogen-Associated Structures and Beyond
by: Ekaterina A. Golenkina, et al.
Published: (2026-05-01)

Biomarkers of Oxidative Stress in Systemic Lupus Erythematosus Patients with Active Nephritis
by: Lu Liu, et al.
Published: (2023-08-01)

Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy
by: Sára Csiha, et al.
Published: (2025-02-01)

sRAGE and early signs of cardiac target organ damage in mild hypertensives
by: Andrea Maria Maresca, et al.
Published: (2019-02-01)

The cardiovascular complications of diabetes: a striking link through protein glycation
by: Ahmad Mousa Numan, et al.
Published: (2020-12-01)

Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury
by: Taro Miyagawa, et al.
Published: (2022-01-01)

Association of acrylamide dietary intake with glycation and oxidative status biomarkers and intakes of advanced glycation end-products or alpha-dicarbonyls
by: Katarína Šebeková, et al.
Published: (2025-04-01)

Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
by: Chinedum Eleazu, et al.
Published: (2019-06-01)

Corrigendum: Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
by: Chinedum Eleazu, et al.
Published: (2019-08-01)

Receptor for advanced glycation end products (RAGE) as a novel biomarker for differentiating drowning from postmortem submersion
by: mariem shafek Keryakous, et al.
Published: (2023-01-01)

RAGE signaling inhibition prevents the malignant phenotypes of pancreatic ductal adenocarcinoma cells
by: Hironori Minami, et al.
Published: (2026-04-01)

Reduced sRAGE Production and ADAM10 Gene Expression in Peripheral Blood Samples of Diabetic Nephropathy Patients
by: Claire Gabriella Dias, et al.
Published: (2022-01-01)